Angela J. Mojica-Espejo
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Modeling Tay-Sachs Disease in Astrocyte-like Cells Reveals Significant Changes in the Transcriptomic Profile.
Journal: International journal of molecular sciences
Published: May 28, 2026
Tay-Sachs disease models: From cellular and animal models to treatment perspectives.
Journal: Molecular genetics and metabolism
Published: January 15, 2026
Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.
Journal: Biomolecules
Published: December 20, 2025
Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Efficiently Rescues GM2 Ganglioside Accumulation in Tay-Sachs Disease.
Journal: Journal of personalized medicine
Published: March 23, 2025
Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay-Sachs Disease.
Journal: Pharmaceutics
Published: March 21, 2025
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 02, 2024
Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB.
Journal: Chembiochem : a European journal of chemical biology
Published: January 29, 2024
A close-up view of the Hunter syndrome.
Journal: Biochemical and biophysical research communications
Published: December 11, 2023
Characterization and expression of domains of Alphaherpesvirus bovine 1/5 envelope glycoproteins B in Komagataella phaffi.
Journal: BMC veterinary research
Published: November 04, 2022
CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors.
Journal: International journal of molecular sciences
Published: August 24, 2022
Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles.
Journal: Scientific reports
Published: June 28, 2022
Last Updated: 09/26/2026